"Designing Growth Strategies is in our DNA"

Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Share and Global Trend By Drug Class (Soluble Guanylate Cyclase (SGC) Stimulators,Prostacyclin and Prostacyclin Analogs, Phosphodiesterase 5 (PDE-5), Endothelin Receptor Antagonists (ERA)), By End User (Hospitals, Clinics, Others), and Geography Forecast till 2022-2029

Region : Global | Report ID: FBI101003 | Status : Ongoing

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Final report will be updated to address the impact of COVID-19 on this particular market

Request PDF Brochure

Refresh Button
Booklet
  • Ongoing
  • 2021
  • 2018-2020

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X